Has Bradley Smith, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,793 in general payments to Bradley Smith, MD across 85 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bradley Smith, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bradley Smith, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bradley Smith, MD

Retina Specialist · Brentwood, MONPI 1588608970

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,885 of the $4,793 with a category attached, or 60.2%. 17 manufacturers reported payments, led by Eyepoint US, Inc. at 39.8% of the total. Reporting peaked in 2024 at $2,516 and has fallen 79.2% since, to $523 in 2025.

$4,793in general payments, 2019–2025

Across 85 payments — averaging $56.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Eyepoint US, Inc.$2K
Regeneron Healthcare Solutions, Inc.$693
AbbVie$449
Genentech USA, Inc.$370
Bausch & Lomb, A Division Of Bausch Health US, LLC$270
Novartis$231
plus $873 from 11 others

$108,281in research payments, 2019–2025

Across 4 payments — averaging $27,070 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eyepoint US, Inc.$108K

What the payments were for

Consulting fees$1,85039%
Travel & lodging$220%
Food & beverage$2,88560%
Gifts$371%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Eyepoint US, Inc.	5	$1,907
Regeneron Healthcare Solutions, Inc.	15	$693
AbbVie(2 entities)	13	$449
Genentech USA, Inc.	18	$370
Bausch & Lomb, A Division Of Bausch Health US, LLC	11	$270
Novartis	3	$231
Bausch & Lomb Americas Inc.	5	$204
Genentech, Inc.	1	$141
Astellas Pharma US Inc	4	$123
Regeneron	1	$119
Alcon	1	$94
Biogen	2	$47
Johnson & Johnson Surgical Vision, Inc.	1	$35
Carl Zeiss Meditec, Inc.	2	$32
ANI Pharmaceuticals, Inc.	1	$31
Harrow Eye, LLC	1	$29
Carl Zeiss Meditec AG	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,793 in reported general payments places this provider in the 65th percentile of 45 retina specialist providers in Missouri.

See all retina specialist providers in Missouri →

Medicare billing

Part B allowed, 2024

$3,067,495

Medicare patients

1,266

Services billed

47,880

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ketorolac Tromethamine	818	$18,820
Prednisolone Acetate	266	$10,749
Brimonidine Tartrate	99	$4,214
Bromfenac Sodium	12	$2,965
Timolol Maleate	184	$1,812
ValacyclovirValacyclovir Hcl	21	$1,414
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	29	$501
Ofloxacin	43	$400
Latanoprost	29	$259
Acetazolamide	13	$235
Dorzolamide Hcl	22	$205
Diclofenac Sodium	13	$166
Prednisone	28	$153

Paid to pharmacies, not to this prescriber.

Other retina specialist in Brentwood

Kevin BlinderBrentwood$333K
Sabin DangBrentwood$174K
Athanasios PapakostasBrentwood$85K
Alia DurraniBrentwood$53K
Barton BlackorbyBrentwood$31K
Ollya FromalBrentwood$14K
Nicholas IafeBrentwood$9K
Dillan PatelBrentwood$5K
William AndersonBrentwood$4K
Prithvi BomdicaBrentwood$4K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →